Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123872222 | 12387222 | 2 | F | 20130130 | 20160714 | 20160519 | 20160721 | EXP | US-DSJP-DSU-2016-116609 | DAIICHI | 0.00 | Y | 0.00000 | 20160721 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123872222 | 12387222 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | |||||
123872222 | 12387222 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG,BID | Y | 21286 | 40 | MG | TABLET | BID | |||||
123872222 | 12387222 | 3 | C | MAALOX ANTACID | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | 30 ML, ONCE EVERY 6HR | 0 | 30 | ML | ORAL SUSPENSION | Q6H | |||||||
123872222 | 12387222 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
123872222 | 12387222 | 5 | C | ANTIVERT /00007101/ | MECLIZINE MONOHYDROCHLORIDENIACIN | 1 | Oral | 25 MG, PRN | 0 | 25 | MG | TABLET | |||||||
123872222 | 12387222 | 6 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | Topical | 2 %, BID | 0 | 2 | PCT | CREAM | BID | ||||||
123872222 | 12387222 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | QD | ||||||
123872222 | 12387222 | 8 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | TABLET | BID | ||||||
123872222 | 12387222 | 9 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | TABLET | |||||||||||
123872222 | 12387222 | 10 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 325 MG, ONCE EVERY 4HR | 0 | 325 | MG | TABLET | Q4H | ||||||
123872222 | 12387222 | 11 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 650 MG, ONCE EVERY 4HR | 0 | 650 | MG | TABLET | Q4H | ||||||
123872222 | 12387222 | 12 | C | LIDOCAIN /00033401/ | LIDOCAINE | 1 | Topical | 5 %, UNK | 0 | 5 | PCT |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123872222 | 12387222 | 1 | Hypertension |
123872222 | 12387222 | 3 | Abdominal discomfort |
123872222 | 12387222 | 4 | Product used for unknown indication |
123872222 | 12387222 | 5 | Dizziness |
123872222 | 12387222 | 6 | Onychomycosis |
123872222 | 12387222 | 7 | Diuretic therapy |
123872222 | 12387222 | 8 | Pancreatic insufficiency |
123872222 | 12387222 | 9 | Gastrooesophageal reflux disease |
123872222 | 12387222 | 10 | Pain |
123872222 | 12387222 | 11 | Body temperature increased |
123872222 | 12387222 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123872222 | 12387222 | HO |
123872222 | 12387222 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123872222 | 12387222 | Coeliac disease | |
123872222 | 12387222 | Colon adenoma | |
123872222 | 12387222 | Diverticulum intestinal | |
123872222 | 12387222 | Dizziness | |
123872222 | 12387222 | Gastrooesophageal reflux disease | |
123872222 | 12387222 | Haematochezia | |
123872222 | 12387222 | Hiatus hernia | |
123872222 | 12387222 | Malabsorption | |
123872222 | 12387222 | Pancreatic disorder | |
123872222 | 12387222 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123872222 | 12387222 | 1 | 20130513 | 201404 | 0 | |
123872222 | 12387222 | 2 | 20130513 | 201404 | 0 |